SCHEMBL5652218

SCHEMBL5652218

CN(C(=O)Oc1ccc(NC(=O)CC(C)(C)C)cn1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
MAPT P10636 3/20 0.48
RAB9A P51151 3/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
LMNA P02545 4/20 0.47
NPSR1 Q6W5P4 2/20 0.47
PABPC1 P11940 1/20 0.47
NPC1 O15118 2/20 0.47
PKM P14618 1/20 0.47
LIPE Q05469 3/20 0.46
CXCR1 P25024 1/20 0.45
CXCR2 P25025 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
ADORA2A P29274 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5649329 0.91 MEN1 (0.46) MEN1KMT2AMAPTRAB9ALMNA
SCHEMBL5649372 0.90 MAPT (0.58) MEN1KMT2AMAPTRAB9ALMNA
SCHEMBL5645173 0.87 ALDH1A1 (0.47) MEN1KMT2AMAPTRAB9AHPGD
SCHEMBL5648582 0.85 ALDH1A1 (0.46) MEN1KMT2AMAPTRAB9ALMNA
SCHEMBL27544645 0.85 LIPE (0.45) MEN1KMT2AMAPTRAB9AGAA
SCHEMBL5644860 0.85 KMT2A (0.49) MEN1KMT2ARAB9ALMNANPSR1
SCHEMBL5648590 0.84 MAPT (0.45) MEN1KMT2AMAPTRAB9ALMNA
SCHEMBL5914606 0.83 KMT2A (0.47) MEN1KMT2AMAPTRAB9AGAA
SCHEMBL5688527 0.83 RAB9A (0.47) MEN1KMT2AMAPTRAB9AHPGD
SCHEMBL5651843 0.82 MEN1 (0.68) MEN1KMT2AMAPTRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160865-A1 Pyridinyl carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636205-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111031-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP claimed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US claimed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO claimed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-20060160865-A1 Pyridinyl carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1636205-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111031-A1 PYRIDINYL CARBAMATES AS HORMONE-SENSITIVE LIPASE INHIBITORS NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL MEN1 2277/4885KMT2A 4150/4885MAPT 4693/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL MEN1 1767/4885KMT2A 4322/4885MAPT 4668/4885
US-20060160865-A1 Pyridinyl carbamates LIPE, PNLIP, LPL MEN1 1310/4885KMT2A 2706/4885MAPT 3814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.